Blue Apron (APRN) Misses Q4 EPS by 6c, Offers Outlook
Get Alerts APRN Hot Sheet
Join SI Premium – FREE
Blue Apron (NYSE: APRN) reported Q4 EPS of ($0.67), $0.06 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $115.5 million versus the consensus estimate of $110.5 million.
GUIDANCE:
Blue Apron sees Q1 2021 revenue of $125-129 million, versus the consensus of $115.4 million.
- Blue Apron today provided an outlook for certain first quarter 2021 financial metrics, reflecting certain assumptions regarding the company’s business including the impact of its operational improvements, trends, historical seasonal factors, the continuing impact of COVID-19 on its business (including as a result of changes in consumer behavior), and plans to increase marketing investments. The following guidance assumes that the company will not experience any unforeseen significant disruptions in its fulfillment operations or supply chain as a result of the COVID-19 pandemic or otherwise. In addition, because the timing of the onion recall recovery remains uncertain, we are not assuming receipt of the up to $2.0 million of credits in our first quarter outlook.
- For the first quarter, the company expects net revenue will grow approximately 23% to 27% year over year to approximately $125 million to $129 million. The company also expects a quarterly sequential and year-over-year increase in Customers for the first quarter of 2021. Assuming similar historical seasonal demand and cost trends, the company expects to incur a net loss of no more than $16.0 million and an adjusted EBITDA loss of no more than $6.0 million.
- For the full year 2021, Blue Apron expects to generate double-digit net revenue growth.
For earnings history and earnings-related data on Blue Apron (APRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share